Wedbush Issues Optimistic Forecast for BCRX Earnings
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) – Equities research analysts at Wedbush increased their Q3 2025 earnings per share estimates for shares of BioCryst Pharmaceuticals in a research report issued to clients and investors on Monday, May 5th. Wedbush analyst L. Chico now forecasts that the biotechnology company will earn $0.04 per share for […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) – Equities research analysts at Wedbush increased their Q3 2025 earnings per share estimates for shares of BioCryst Pharmaceuticals in a research report issued to clients and investors on Monday, May 5th. Wedbush analyst L. Chico now forecasts that the biotechnology company will earn $0.04 per share for […]
